Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.
Lymphatic filariasis is a disease of considerable socioeconomic burden in the tropics. Presently used antifilarial drugs are able to strongly reduce transmission and will thus ultimately lower the burden of morbidity associated with the infection, however, a chemotherapeutic principle that directly...
Main Authors: | Alexander Yaw Debrah, Sabine Mand, Sabine Specht, Yeboah Marfo-Debrekyei, Linda Batsa, Kenneth Pfarr, John Larbi, Bernard Lawson, Mark Taylor, Ohene Adjei, Achim Hoerauf |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2006-09-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.0020092 |
Similar Items
-
Macrofilaricidal Activity in Wuchereria bancrofti after 2 Weeks Treatment with a Combination of Rifampicin plus Doxycycline
by: Alexander Yaw Debrah, et al.
Published: (2011-01-01) -
Chemotherapy of filariasis – established strategies and new developments
by: Specht, Sabine, et al.
Published: (2013-06-01) -
Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.
by: Tarik Attout, et al.
Published: (2009-12-01) -
VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms
by: Grażyna Gadomska, et al.
Published: (2017-01-01) -
Review of Dancing Parasites in Lymphatic Filariasis
by: Christoph F. Dietrich, et al.
Published: (2019-03-01)